Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Kogami

Masakazu Kogami, Aichi JP

Patent application numberDescriptionPublished
20120101137NOVEL THIOPHENECARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL USE THEREOF - The object of the present invention is to provide a compound having a glucokinase-activating effect.04-26-2012

Mitsuru Kogami, Tochigi JP

Patent application numberDescriptionPublished
20100102063LID BODY OPENING AND CLOSING DEVICE - In order for a lid body 04-29-2010
20100102064LID BODY OPENING AND CLOSING DEVICE - A lid body 04-29-2010

Toshihiro Kogami, Kyoto JP

Patent application numberDescriptionPublished
20080210978SEMICONDUCTOR DEVICE - A semiconductor device includes: a gate electrode formed above a semiconductor region; a drain region and a source region formed in portions of the semiconductor region located below sides of the gate electrode in a gate length direction, respectively; a plurality of drain contacts formed on the drain region to be spaced apart in a gate width direction of the gate electrode; and a plurality of source contacts formed on the source region to be spaced apart in the gate width direction of the gate electrode. The intervals between the drain contacts are greater than the intervals between the source contacts.09-04-2008
20090059453SEMICONDUCTOR INTEGRATED CIRCUIT - A semiconductor integrated circuit includes an external pad, a ground line, a first protection circuit between the external pad and the ground line, and a second protection circuit between the external pad and the ground line. The second protection circuit is formed by a first protection element, a second protection element, and a resistor. With this structure, the resistance value of the resistor is set to an arbitrary value, so that an unnecessary current which would be generated at the time of power-off of the LSI can be decreased to a value which does not deteriorate the reliability of the LSI.03-05-2009
20110227197SEMICONDUCTOR INTEGRATED CIRCUIT COMPRISING ELECTRO STATIC DISCHARGE PROTECTION ELEMENT - An electro static discharge protection element being formed by a diode including a well region of a first conductivity type on a surface of a semiconductor substrate, and a first diffusion layer of a second conductivity type in the well region. The first diffusion layer is surrounded by a second diffusion layer of the first conductivity type in the well region. The first diffusion layer has a surface on which a first contact region connected to an input/output terminal is formed. The first diffusion layer has a surface on which a second contact region connected to a reference voltage terminal is formed.09-22-2011
20110284963SEMICONDUCTOR DEVICE - A semiconductor device includes: a gate electrode formed above a semiconductor region; a drain region and a source region formed in portions of the semiconductor region located below sides of the gate electrode in a gate length direction, respectively; a plurality of drain contacts formed on the drain region to be spaced apart in a gate width direction of the gate electrode; and a plurality of source contacts formed on the source region to be spaced apart in the gate width direction of the gate electrode. The intervals between the drain contacts are greater than the intervals between the source contacts.11-24-2011

Patent applications by Toshihiro Kogami, Kyoto JP

Yasunori Kogami, Hanamaki-Shi JP

Patent application numberDescriptionPublished
20100040739GEL TYPE ENTERAL NUTRIENT - A gel type enteral nutrient, which is excellent in the form-maintaining capability of solid matter (gel) in the stomach, is not easily disintegrated or dissolved even depending upon a pH change, shows little change in the physical properties such as water liberation, or the like even during long-term stage, can be thermally sterilized and has a preferable property passing through a feeding tube, can be prepared by blending agar and alginic acid and/or its salt, and further soybean protein as a nitrogen source. It is expected to exert effects that neither gastro-esophageal reflux nor leakage of the nutrient occur when intaking the gel type enteral nutrient of the present invention.02-18-2010

Yiji Kogami, Kanagawa JP

Patent application numberDescriptionPublished
20120088770ALPHA HELIX MIMETICS AND METHODS RELATING THERETO - Alpha-helix mimetic structures and compounds represented by the formula (I) wherein the general formula and the definition of each symbol are as defined in the specification, a chemical library relating thereto, and methods relating thereto, are disclosed. Applications of these compounds in the treatment of medical conditions, e.g., cancer diseases, fibrotic diseases, and pharmaceutical compositions comprising the mimetics are further disclosed.04-12-2012

Yuji Kogami, Kanagawa JP

Patent application numberDescriptionPublished
20110092459ALPHA HELIX MIMETICS AND METHODS RELATING THERETO - Alpha-helix mimetic structures and compounds represented by the formula (I) wherein the general formula and the definition of each symbol are as defined in the specification, a compound relating thereto, and methods relating thereto, are disclosed. Applications of these compounds in the treatment of medical conditions, e.g., cancer diseases, fibrotic diseases, and pharmaceutical compositions comprising the mimetics are further disclosed.04-21-2011
20110263607ALPHA HELIX MIMETICS IN THE TREATMENT OF CANCER - Alpha-helix mimetic structures and compounds represented by the formula (I) wherein the general formula and the definition of each symbol are as defined in the specification, a compound relating thereto, and methods relating thereto, are disclosed. Applications of these compounds in the treatment of medical conditions, e.g., cancer diseases, fibrotic diseases, and pharmaceutical compositions comprising the mimetics are further disclosed.10-27-2011